Back to results
US 12,741,926 B2Granted
Lipoxygenase inhibitors
AssigneeSRI International
InventorsLing Jong, Nathan Collins, Raymond Ng
Life of this patent
Estimating the term…
Abstract
Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.
Claims10
A compound, wherein the compound is selected from:
- and
- a pharmaceutically acceptable salt thereof.
A compound, wherein the compound is selected from:
- and a pharmaceutically acceptable salt thereof.
A compound, wherein the compound is selected from:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.